Status:
COMPLETED
Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
6-18 years
Brief Summary
This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during Levemir® treatment.
Eligibility Criteria
Inclusion
- Informed consent obtained prior to any trial-related activities
- Any patient with diabetes type 1 is eligible for the study, including newly
- The selection of the patients will be at the discretion of the individual physician
Exclusion
- Type 2 diabetes
- Currently treated with Levemir®
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT00704574
Start Date
January 1 2008
End Date
June 1 2010
Last Update
January 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Lund, Sweden, 221 85